A Phase 1 interventional study of ibuprofen and Placebo in Osteoarthritis, Knee, sponsored by Merck Sharp & Dohme LLC. Completed. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2015-04-10.
Sponsored by Merck Sharp & Dohme LLC (part of Merck & Co., Inc) · Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of the study is to see if generic ibuprofen has an effect on osteoarthritis knee pain during a series of timed walks on a treadmill.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 624 are open to participants now.
This study's enrollment of 33 is below the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Browse Osteoarthritis, Knee studies →Merck Sharp & Dohme LLC is the lead sponsor of 2,167 studies on the registry; 132 are open to participants now.
Of its 504 completed or terminated interventional studies of FDA-regulated products, 371 (74%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
TIA (transient ischaemic attack)
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Ibuprofen
Drug: ibuprofen
Placebo 1
Drug: Placebo
Placebo 2
Drug: Placebo
Patients will receive 800 mg ibuprofen in one of the three treatment periods.
Patients will receive placebo to ibuprofen in two of the three treatment periods.
Change in Average Pain Intensities Measured From the Pre-Treatment Walk (Baseline) at 3 Post-Treatment Walks
Pain intensities(PIs) were measured at pre-dose and 3 post-dose walks (15 Minutes Each Separated by a 45-Minute Rest Interval) on an 11 point scale(0=no pain; 10=worst pain) and averaged for each walk. Change from baseline was average of post-dose PIs minus average of pre-dose PI.
Time frame: All pain intensities measured from the pre-treatment walk and 3 post-treatment walks (within 3 and half hours post dose, 15 minutes each walk separated by a 45-minute rest interval)
First Patient Entered 16 Mar 2007 Multicenter, 3 sites
| Milestone | Placebo-Placebo-Ibuprofen | Placebo-Ibuprofen-Placebo | Ibuprofen-Placebo-Placebo |
|---|---|---|---|
| Started | 11 | 11 | 11 |
| Completed | 11 | 11 | 11 |
| Not completed | 0 | 0 | 0 |
| Milestone | Placebo-Placebo-Ibuprofen | Placebo-Ibuprofen-Placebo | Ibuprofen-Placebo-Placebo |
|---|---|---|---|
| Started | 11 | 11 | 11 |
| Completed | 11 | 11 | 11 |
| Not completed | 0 | 0 | 0 |
| Milestone | Placebo-Placebo-Ibuprofen | Placebo-Ibuprofen-Placebo | Ibuprofen-Placebo-Placebo |
|---|---|---|---|
| Started | 11 | 11 | 11 |
| Completed | 11 | 11 | 11 |
| Not completed | 0 | 0 | 0 |
Pain intensities(PIs) were measured at pre-dose and 3 post-dose walks (15 Minutes Each Separated by a 45-Minute Rest Interval) on an 11 point scale(0=no pain; 10=worst pain) and averaged for each walk. Change from baseline was average of post-dose PIs minus average of pre-dose PI.
| Units on a Scale | Ibuprofen | Placebo 1 | Placebo 2 |
|---|---|---|---|
| Change in Average Pain Intensities Measured From the Pre-Treatment Walk (Baseline) at 3 Post-Treatment Walks | 0.24 ± 0.77 | 0.18 ± 0.77 | 0.18 ± 0.77 |
Collected over From consent to 14 day follow up after all treatment periods was from 16-Mar-2007 to 10-Dec-2007. First study dosing to last dosing period was from 23-Mar-2007 to 03-Dec-2007.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Placebo-Placebo-Ibuprofen | — | 0/11 (0%) | 3/11 (27.3%) |
| Placebo-Ibuprofen-Placebo | — | 0/11 (0%) | 3/11 (27.3%) |
| Ibuprofen-Placebo-Placebo | — | 1/11 (9.1%) | 3/11 (27.3%) |
| Event | Placebo-Placebo-Ibuprofen | Placebo-Ibuprofen-Placebo | Ibuprofen-Placebo-Placebo |
|---|---|---|---|
| Breast Ductal Cancer InfiltratingNeoplasms benign, malignant and unspecified (incl cysts and polyps) | 0/11 | 0/11 | 1/11 |
| Event | Placebo-Placebo-Ibuprofen | Placebo-Ibuprofen-Placebo | Ibuprofen-Placebo-Placebo |
|---|---|---|---|
| DiarrheaGastrointestinal disorders | 0/11 | 1/11 | 0/11 |
| Boil on ButtockInfections and infestations | 0/11 | 0/11 | 1/11 |
| Cold SymptomsInfections and infestations | 1/11 | 0/11 | 0/11 |
| Urinary Track InfectionInfections and infestations | 1/11 | 0/11 | 0/11 |
| Groin PainMusculoskeletal and connective tissue disorders | 0/11 | 1/11 | 0/11 |
| Hip DiscomfortMusculoskeletal and connective tissue disorders | 0/11 | 1/11 | 0/11 |
| Pain in Joint involving handMusculoskeletal and connective tissue disorders | 0/11 | 1/11 | 0/11 |
| Pain in HipMusculoskeletal and connective tissue disorders | 0/11 | 0/11 | 1/11 |
| Tibia PainMusculoskeletal and connective tissue disorders | 0/11 | 1/11 | 0/11 |
| Unilateral Leg PainMusculoskeletal and connective tissue disorders | 0/11 | 0/11 | 1/11 |
| Age, Continuous(years) | Overall Study |
|---|---|
| Mean | 60.78 (47 to 80) |
| Sex: Female, Male(Participants) | Overall Study |
|---|---|
| Female | 8 |
| Male | 25 |
No study locations are listed for this record.
The record gives a start of Mar 2007, a primary completion of Dec 2007 and a completion of Dec 2007. It does not say whether these dates are actual or estimated.
Results were first posted in Jul 2009, 1 year 7 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ibuprofen